These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 26395087)

  • 1. Development of Small-Molecule Trypanosoma brucei N-Myristoyltransferase Inhibitors: Discovery and Optimisation of a Novel Binding Mode.
    Spinks D; Smith V; Thompson S; Robinson DA; Luksch T; Smith A; Torrie LS; McElroy S; Stojanovski L; Norval S; Collie IT; Hallyburton I; Rao B; Brand S; Brenk R; Frearson JA; Read KD; Wyatt PG; Gilbert IH
    ChemMedChem; 2015 Nov; 10(11):1821-36. PubMed ID: 26395087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and Synthesis of Brain Penetrant Trypanocidal N-Myristoyltransferase Inhibitors.
    Bayliss T; Robinson DA; Smith VC; Brand S; McElroy SP; Torrie LS; Mpamhanga C; Norval S; Stojanovski L; Brenk R; Frearson JA; Read KD; Gilbert IH; Wyatt PG
    J Med Chem; 2017 Dec; 60(23):9790-9806. PubMed ID: 29125744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of a novel class of orally active trypanocidal N-myristoyltransferase inhibitors.
    Brand S; Cleghorn LA; McElroy SP; Robinson DA; Smith VC; Hallyburton I; Harrison JR; Norcross NR; Spinks D; Bayliss T; Norval S; Stojanovski L; Torrie LS; Frearson JA; Brenk R; Fairlamb AH; Ferguson MA; Read KD; Wyatt PG; Gilbert IH
    J Med Chem; 2012 Jan; 55(1):140-52. PubMed ID: 22148754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fragment-Based Discovery of Non-bisphosphonate Binders of Trypanosoma brucei Farnesyl Pyrophosphate Synthase.
    Münzker L; Petrick JK; Schleberger C; Clavel D; Cornaciu I; Wilcken R; Márquez JA; Klebe G; Marzinzik A; Jahnke W
    Chembiochem; 2020 Nov; 21(21):3096-3111. PubMed ID: 32537808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Trypanosoma brucei AdoMetDC Inhibitors Using a High-Throughput Mass Spectrometry-Based Assay.
    Volkov OA; Cosner CC; Brockway AJ; Kramer M; Booker M; Zhong S; Ketcherside A; Wei S; Longgood J; McCoy M; Richardson TE; Wring SA; Peel M; Klinger JD; Posner BA; De Brabander JK; Phillips MA
    ACS Infect Dis; 2017 Jul; 3(7):512-526. PubMed ID: 28350440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From on-target to off-target activity: identification and optimisation of Trypanosoma brucei GSK3 inhibitors and their characterisation as anti-Trypanosoma brucei drug discovery lead molecules.
    Woodland A; Grimaldi R; Luksch T; Cleghorn LA; Ojo KK; Van Voorhis WC; Brenk R; Frearson JA; Gilbert IH; Wyatt PG
    ChemMedChem; 2013 Jul; 8(7):1127-37. PubMed ID: 23776181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-based design of potent and selective Leishmania N-myristoyltransferase inhibitors.
    Hutton JA; Goncalves V; Brannigan JA; Paape D; Wright MH; Waugh TM; Roberts SM; Bell AS; Wilkinson AJ; Smith DF; Leatherbarrow RJ; Tate EW
    J Med Chem; 2014 Oct; 57(20):8664-70. PubMed ID: 25238611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and synthesis of N-(3-sulfamoylphenyl)amides as Trypanosoma brucei leucyl-tRNA synthetase inhibitors.
    Li Z; Xin W; Wang Q; Zhu M; Zhou H
    Eur J Med Chem; 2021 May; 217():113319. PubMed ID: 33725631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and synthesis of α-phenoxy-N-sulfonylphenyl acetamides as Trypanosoma brucei Leucyl-tRNA synthetase inhibitors.
    Xin W; Li Z; Wang Q; Du J; Zhu M; Zhou H
    Eur J Med Chem; 2020 Jan; 185():111827. PubMed ID: 31732256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective inhibitors of protozoan protein N-myristoyltransferases as starting points for tropical disease medicinal chemistry programs.
    Bell AS; Mills JE; Williams GP; Brannigan JA; Wilkinson AJ; Parkinson T; Leatherbarrow RJ; Tate EW; Holder AA; Smith DF
    PLoS Negl Trop Dis; 2012; 6(4):e1625. PubMed ID: 22545171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and structure solution of fragment hits against kinetoplastid N-myristoyltransferase.
    Robinson DA; Wyatt PG
    Acta Crystallogr F Struct Biol Commun; 2015 May; 71(Pt 5):586-93. PubMed ID: 25945713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lead optimization of a pyrazole sulfonamide series of Trypanosoma brucei N-myristoyltransferase inhibitors: identification and evaluation of CNS penetrant compounds as potential treatments for stage 2 human African trypanosomiasis.
    Brand S; Norcross NR; Thompson S; Harrison JR; Smith VC; Robinson DA; Torrie LS; McElroy SP; Hallyburton I; Norval S; Scullion P; Stojanovski L; Simeons FR; van Aalten D; Frearson JA; Brenk R; Fairlamb AH; Ferguson MA; Wyatt PG; Gilbert IH; Read KD
    J Med Chem; 2014 Dec; 57(23):9855-69. PubMed ID: 25412409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homology modeling and molecular dynamics simulation of N-myristoyltransferase from protozoan parasites: active site characterization and insights into rational inhibitor design.
    Sheng C; Ji H; Miao Z; Che X; Yao J; Wang W; Dong G; Guo W; Lü J; Zhang W
    J Comput Aided Mol Des; 2009 Jun; 23(6):375-89. PubMed ID: 19370313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Molecular Hybridization Approach for the Design of Potent, Highly Selective, and Brain-Penetrant N-Myristoyltransferase Inhibitors.
    Harrison JR; Brand S; Smith V; Robinson DA; Thompson S; Smith A; Davies K; Mok N; Torrie LS; Collie I; Hallyburton I; Norval S; Simeons FRC; Stojanovski L; Frearson JA; Brenk R; Wyatt PG; Gilbert IH; Read KD
    J Med Chem; 2018 Sep; 61(18):8374-8389. PubMed ID: 30207721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenosine analogues as inhibitors of Trypanosoma brucei phosphoglycerate kinase: elucidation of a novel binding mode for a 2-amino-N(6)-substituted adenosine.
    Bressi JC; Choe J; Hough MT; Buckner FS; Van Voorhis WC; Verlinde CL; Hol WG; Gelb MH
    J Med Chem; 2000 Nov; 43(22):4135-50. PubMed ID: 11063610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization and selective inhibition of myristoyl-CoA:protein N-myristoyltransferase from Trypanosoma brucei and Leishmania major.
    Panethymitaki C; Bowyer PW; Price HP; Leatherbarrow RJ; Brown KA; Smith DF
    Biochem J; 2006 Jun; 396(2):277-85. PubMed ID: 16480339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-myristoyltransferase inhibitors as new leads to treat sleeping sickness.
    Frearson JA; Brand S; McElroy SP; Cleghorn LA; Smid O; Stojanovski L; Price HP; Guther ML; Torrie LS; Robinson DA; Hallyburton I; Mpamhanga CP; Brannigan JA; Wilkinson AJ; Hodgkinson M; Hui R; Qiu W; Raimi OG; van Aalten DM; Brenk R; Gilbert IH; Read KD; Fairlamb AH; Ferguson MA; Smith DF; Wyatt PG
    Nature; 2010 Apr; 464(7289):728-32. PubMed ID: 20360736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Thienopyrimidine Inhibitors of
    Bell AS; Yu Z; Hutton JA; Wright MH; Brannigan JA; Paape D; Roberts SM; Sutherell CL; Ritzefeld M; Wilkinson AJ; Smith DF; Leatherbarrow RJ; Tate EW
    J Med Chem; 2020 Jul; 63(14):7740-7765. PubMed ID: 32575985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-Based Virtual Screening and Biochemical Evaluation for the Identification of Novel Trypanosoma brucei Aldolase Inhibitors.
    Ferreira LLG; Ferreira RS; Palomino DL; Andricopulo AD
    Curr Top Med Chem; 2018; 18(5):397-405. PubMed ID: 29701141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3-(Oxazolo[4,5-b]pyridin-2-yl)anilides as a novel class of potent inhibitors for the kinetoplastid Trypanosoma brucei, the causative agent for human African trypanosomiasis.
    Ferrins L; Rahmani R; Sykes ML; Jones AJ; Avery VM; Teston E; Almohaywi B; Yin J; Smith J; Hyland C; White KL; Ryan E; Campbell M; Charman SA; Kaiser M; Baell JB
    Eur J Med Chem; 2013 Aug; 66():450-65. PubMed ID: 23831695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.